Evidence map›Paper›PMID 16604083›Full record

ArticleNature structural & molecular biology2006

Nucleophosmin is selectively deposited on mRNA during polyadenylation.

Viswanathan Palaniswamy, Karen C M Moraes, Carol J Wilusz, Jeffrey Wilusz

Open access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Expression and functional studies on the noncoding RNA, PRINS.International journal of molecular sciences · 2012
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Viswanathan PalaniswamyDepartment of Microbiology, Immunology & Pathology, Colorado State University, 1619 Campus Delivery, Fort Collins, Colorado 80523, USA.
Karen C M Moraes
Carol J Wilusz
Jeffrey Wilusz
Colorado State University · US

Funding

Mechanism of Regulation of mRNA StabilityR01GM072481 · NIGMS · COLORADO STATE UNIVERSITY-FORT COLLINS · PI WILUSZ, JEFFREY · 2004 to 2011
$2.7M
NIGMS NIH HHS GM072481NIGMS NIH HHS R01 GM072481
6 · The paper itself

Abstract

Nucleophosmin (NPM), an abundant, predominantly nucleolar protein that influences numerous cellular processes, was shown to specifically associate with the bodies of messenger RNAs as a result of the process of 3'-end formation. NPM deposition requires polyadenylation but not the 3' cleavage event to occur on the transcript. Furthermore, the protein does not associate with RNAs bearing a preformed poly(A) tail or with mRNAs that have undergone cleavage but not polyadenylation. A region within 10 bases upstream of the AAUAAA element is required for NPM association, but deposition of the protein seems to be sequence independent. NPM association with poly(A)(+) mRNAs was also demonstrated in vivo. NPM, therefore, represents a mark left on transcripts as a result of 3'-end processing and may have a role in one or more of a variety of post-transcriptional processes influenced by the polyadenylation event.

Indexed as

Amino Acid SequenceBase SequenceHeLa CellsHumansMolecular Sequence DataMolecular WeightNuclear ProteinsNucleophosminPolyadenylationProtein BindingRNA, MessengerSubstrate SpecificityNPM1 protein, humanNuclear ProteinsNucleophosminRNA, Messenger

Identifiers

PMID16604083
PMCPMC2811576
OpenAlexW2085011919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.